Skip to main content
SpringerLink
Log in

Leitlinien zur Herzschrittmachertherapie

  • LEITLINIEN/KOMMENTARE/POSITIONSPAPIERE
  • Published:
Zeitschrift für Kardiologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lemke B, Fischer W, Schulten HK (1996) Richtlinien zur Herzschrittmachertherapie. Indikationen, Systemwahl, Nachsorge. “Kommission für Klinische Kardiologie” der Deutschen Gesellschaft für Kardiologie—Herz- und Kreislaufforschung, Arbeitsgruppen “Herzschrittmacher” und “Arrhythmie”. Z Kardiol 85:611–627

    Google Scholar 

  2. Gregoratos G, Abrams J, Epstein AE et al ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers und antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation) (2002). www.acc.org/clinical/guidelines/pacemaker/pacemaker.pdf

  3. Strasberg B, Amat-Y-Leon F, Dhingra RC et al (1981) Natural history of chronic second-degree atrioventricular nodal block. Circulation 63:1043–1049

    PubMed  Google Scholar 

  4. Dhingra RC, Denes P, Wu D, Chuquimia R, Rosen KM (1974) The significance of second degree atrioventricular block and bundle branch block: observations regarding site and type of block. Circulation 49:638–646

    PubMed  Google Scholar 

  5. Dhingra RC, Wyndham C, Bauernfeind R et al (1979) Significance of block distal to the His bundle induced by atrial pacing in patients with chronic bifascicular block. Circulation 60:1455–1464

    PubMed  Google Scholar 

  6. Scheinman MM,Peters RW, Sauvè MJet al (1982) Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 50:1316–1322

    Article  PubMed  Google Scholar 

  7. Perloff JK, Stevenson WG, Roberts NK et al (1984) Cardiac involvement in myotonic muscular dystrophy (Steinert’s disease): a prospective study of 25 patients. Am J Cardiol 54:1074–1081

    PubMed  Google Scholar 

  8. Charles R, Holt S, Kay JM, Epstein EJ, Rees JR (1981) Myocardial ultrastructure and the development of atrioventricular block in Kearns-Sayre syndrome. Circulation 63:214–219

    PubMed  Google Scholar 

  9. Stevenson WG, Perloff JK, Weiss JN, Anderson TL (1990) Facioscapulohumeral muscular dystrophy: evidence for selective, genetic electrophysiologic cardiac involvement. J Am Coll Cardiol 15:292–299

    PubMed  Google Scholar 

  10. Shaw DB, Kerwick CA, Veale D, Gowers J, Whistance T (1985) Survival in second degree atrioventricular block. Br Heart J 53:587–593

    PubMed  Google Scholar 

  11. Moak JP, Barron KS, Hougen TJ et al (2001) Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 37:238–242

    Article  PubMed  Google Scholar 

  12. Pinsky WW, Gillette PC, Garson A Jr, McNamara DG (1982) Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 69:728–733

    PubMed  Google Scholar 

  13. Michaëlsson M, Jonzon A, Riesenfeld T (1995) Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 92:442–449

    PubMed  Google Scholar 

  14. Brignole M, Menozzi C, Moya A et al (2001) Mechanism of synkope in patients with bundle branch block and negative electrophysiological test. Circulation 104:2045–2050

    PubMed  Google Scholar 

  15. McAnulty JH, Rahimtoola SH, Murphy ES et al (1982) Natural history of „high risk“ bundle-branch block: Final report of a prospective study. N Engl J Med 307:137–143

    PubMed  Google Scholar 

  16. Brignole M, Alboni P, Benditt D et al (2004) Guidelines on Management (Diagnosis and Treatment) of Syncope—Update 2004. Europace 6:467–537

    Article  PubMed  Google Scholar 

  17. Scheinman MM, Peters RW, Sauvè MJ et al (1982) Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 50:1316–1322

    Article  PubMed  Google Scholar 

  18. Cazeau S, Leclercq C, Lavergne T et al Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344:873–880

    Article  PubMed  Google Scholar 

  19. Auricchio A, Stellbrink C, Block M et al for the PATH-CHF Study Group (1999) The effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 99:2993–3001

    PubMed  Google Scholar 

  20. Abraham WT, Fisher WG, Smith AL et al, for the MIRACLE Study Group (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853

    Article  PubMed  Google Scholar 

  21. Cleland JGF, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in hear failure. N Engl J Med 352:1539–1549

    Article  PubMed  Google Scholar 

  22. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure. N Engl J Med 350:2140–2150

    Article  PubMed  Google Scholar 

  23. Auricchio A, Stellbrink C, Sack S et al for the Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group (2002) Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 39:2026–2033

    Article  PubMed  Google Scholar 

  24. Higgins SL, Hummel JD, Niazi IK et al (2003) Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 42:1454–1459

    Article  PubMed  Google Scholar 

  25. Auricchio A, Stellbrink C, Butter C et al (2003) Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 42:2109–2116

    Article  PubMed  Google Scholar 

  26. Stellbrink C, Auricchio A, Lemke B, von Scheidt W, Vogt J (2003) Positionspapier zur kardialen Resynchronisationstherapie. Z Kardiol 92:96–103

    Article  PubMed  Google Scholar 

  27. Col JJ, Weinberg SL (1972) The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol 29:344–350

    Article  PubMed  Google Scholar 

  28. Ritter WS, Atkins J, Blomqvist CG, Mullins CB (1976) Permanent pacing in patients with transient trifascicular block during acute myocardial infarction. Am J Cardiol 38:205–208

    Article  PubMed  Google Scholar 

  29. Seidl K, Schuchert A, Tebbenjohanns J et al (2005) Kommentar zu den Leitlinien zur Diagnostik und Therapie von Synkopen—der Europäischen Gesellschaft für Kardiologie 2001. www.dgk.org/leitlinien/LLSynkopen 2005.pdf

  30. Bernstein AD, Daubert JC, Fletcher RD et al (2002) The Revised NASPE/BPEG Generic Code for Antibradycardia, Adaptive-Rate, and Multisite Pacing. PACE 25:260–264

    PubMed  Google Scholar 

  31. Andersen HR, Nielsen JC, Thomsen PEB et al (1997) Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350:1210–1216

    Article  PubMed  Google Scholar 

  32. Connolly SJ, Kerr CR, Gent M et al (2000) Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 342:1385–1391

    Article  PubMed  Google Scholar 

  33. Lamas GA, Kerry LL, Sweeney MO et al (2002) Ventricular pacing or dualchamber pacing for sinus-node dysfunction. N Engl J Med 346:1854–1862

    Article  PubMed  Google Scholar 

  34. Tang ASL, Roberts RS, Kerr C et al (2001) Relationship between pacemaker dependency and the effect of pacing mode on cardiovascular outcomes. Circulation 103:3081–3085

    PubMed  Google Scholar 

  35. Mattioli AV, Vivoli D, Mattioli G (1998) Influence of pacing modalities on the incidence of atrial fibrillation in patients without prior atrial fibrillation. A prospective study. Eur Heart J 19:282–286

    Article  PubMed  Google Scholar 

  36. Lamas GA, Orav EJ, Stambler BS et al, for the Pacemaker Selection in the Elderly Investigators (1998) Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 338:1097–1104

    Article  PubMed  Google Scholar 

  37. Kerr CL, Connolly SJ, Abdollah H et al (2004) Canadian trial of physiological pacing. Effects of physiological pacing during long-term follow-up. Circulation 109:357–362

    Article  PubMed  Google Scholar 

  38. Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937

    Article  PubMed  Google Scholar 

  39. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Thomsen PEB (1994) Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 344:1523–1528

    Article  PubMed  Google Scholar 

  40. Aggarwal RK, Connelly DT, Ray SG et al (1995) Early complications of permanent pacemaker implantation: No difference between dual and single chamber systems. Br Heart J 73:571–575

    PubMed  Google Scholar 

  41. Rosenqvist M, Brandt J, Schüller H (1988) Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 116:16–22

    Article  PubMed  Google Scholar 

  42. Wiegand UKH, Schier H, Bode F et al (1998) Should unipolar leads be implanted in the atrium? A Holter electrocardiographic comparison of threshold adapted unipolar and high sensitive bipolar sensing. PACE 21:1601–1608

    PubMed  Google Scholar 

  43. Gross JN, Platt S, Ritacco R et al (1992) The clinical relevance of the elektromyopotential oversensing in current unipolar devices. PACE 15:2023–2027

    PubMed  Google Scholar 

  44. Moller M, Arnsbo P (1996) Appraisal of pacing lead performance from the Danish Pacemaker Register. PACE 19:1327–1336

    PubMed  Google Scholar 

  45. Wiegand UKH, Bode F, Bonnemeier H, Tölg R, Peters W, Katus HA (2001) Incidence and predictors of pacemaker dysfunction with unipolar ventricular lead configuration. Can we identify patients who benefit from bipolar electrodes? PACE 24:1383–1388

    PubMed  Google Scholar 

  46. Martinelli M, Costa R, Nishioka S et al (2002) Criteria for pacemaker explant in patients without a precise indication for pacemaker implantation. PACE 25:272–277

    PubMed  Google Scholar 

  47. Hemmer W, Fröhlig G, Markewitz A (2002) Kommentar zu den NASPE-Empfehlungen zur Entfernung von permanent implantierten, transvenösen Herzschrittmacher- und Defibrillatorsonden. Z Kardiol 91:956–968

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinikum Lüdenscheid, Innere Klinik III, Kardiologie und Angiologie, Paulmannshöher Str. 14, 58515, Lüdenscheid

    B. Lemke

  2. Cardioangiologisches Centrum Bethanien, Im Prüfling 23, 60389, Frankfurt/Main

    B. Nowak

  3. Universität Leipzig Zentrum, Innere Medizin Medizinische Klinik I, Kardiologie und Angiologie, Johannisallee 32, 04103, Leipzig

    D. Pfeiffer

Authors
  1. B. Lemke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Nowak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Pfeiffer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Lemke.

Additional information

Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie—Herz- und Kreislaufforschung e.V. Bearbeitet im Auftrag der Kommission für Klinische Kardiologie R. H. Strasser, D. Andresen, F. de Haan, G. Ertl, H. Mudra, A. Osterspey, H. J. Trappe, K. Werdan, außerdem G. Arnold, H. M. Hoffmeister, E. Fleck und der Arbeitsgruppe Herzschrittmacher der DGK W. Hemmer, B. Nowak, C. Israel, L. Krämer, J. Neuzner, D. Pfeiffer, K. Rybak, A. Schuchert, U. Wiegand

Diese Leitlinie ist eine wissenschaftlich und systematisch erarbeitete Stellungnahme der Deutschen Gesellschaft für Kardiologie—Herz- und Kreislaufforschung e.V. (DGK), die den gegenwärtigen Erkenntnisstand zum Thema wiedergibt und allen behandelnden Ärzten und ihren Patienten die Entscheidungsfindung für eine angemessene Behandlung dieser spezifischen Krankheitssituation erleichtern soll. Diese Leitlinie ersetzt nicht die ärztliche Evaluation des individuellen Patienten und die Anpassung der Diagnostik und Therapie an die spezifische Situation des einzelnen Patienten.

Empfehlungsgrad Definition

I. Evidenz oder allgemeine Übereinkunft, dass eine Therapieform oder eine diagnostische Maßnahme effektiv, nützlich oder heilsam ist.

II. Widersprüchliche Evidenz und/oder unterschiedliche Meinungen über den Nutzen/die Effektivität einer Therapieform oder einer diagnostischen Maßnahme.

IIa. Evidenzen/Meinungen favorisieren den Nutzen bzw. die Effektivität einer Maßnahme.

IIb. Nutzen/Effektivität einer Maßnahme ist weniger gut durch Evidenzen/Meinungen belegt.

Evidenzniveau Definition

A. Die Empfehlung wird mindestens durch zwei randomisierte Studien gestützt.

B. Die Empfehlung wird durch eine randomisierte Studie und/oder eine Metaanalyse nicht-randomisierter Studien gestützt.

C. Konsensus-Meinung von Experten, basierend auf Studien und klinischer Erfahrung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lemke, B., Nowak, B. & Pfeiffer, D. Leitlinien zur Herzschrittmachertherapie. ZS Kardiologie 94, 704–720 (2005). https://doi.org/10.1007/s00392-005-0269-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-005-0269-3

Search

Navigation